APA (7th ed.) Citation

Lombardo, F. L., Spila Alegiani, S., Mayer, F., Cipriani, M., Lo Giudice, M., Ludolph, A. C., . . . Lauranzano, E. (2023). A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): The statistical analysis plan of TUDCA-ALS trial. Trials, 24(1), 1. https://doi.org/10.1186/s13063-023-07638-w

Chicago Style (17th ed.) Citation

Lombardo, Flavia L., et al. "A Randomized Double-blind Clinical Trial on Safety and Efficacy of Tauroursodeoxycholic Acid (TUDCA) as Add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS): The Statistical Analysis Plan of TUDCA-ALS Trial." Trials 24, no. 1 (2023): 1. https://doi.org/10.1186/s13063-023-07638-w.

MLA (9th ed.) Citation

Lombardo, Flavia L., et al. "A Randomized Double-blind Clinical Trial on Safety and Efficacy of Tauroursodeoxycholic Acid (TUDCA) as Add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS): The Statistical Analysis Plan of TUDCA-ALS Trial." Trials, vol. 24, no. 1, 2023, p. 1, https://doi.org/10.1186/s13063-023-07638-w.